Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally.
Alkermes stock last closed at $29.32, down 0.2% from the previous day, and has decreased 0.14% in one year. It has underperformed other stocks in the Biotechnology industry by 0.02 percentage points. Alkermes stock is currently +34.8% from its 52-week low of $21.75, and -9.03% from its 52-week high of $32.23.
At the moment, there are 166.12M ALKS shares outstanding. The market cap of ALKS is $4.87B. In the past 24 hours, 601,380 ALKS shares were traded.
How to Buy Alkermes Stock
Wondering how to invest in Alkermes stock? Here's how.
Figure out where to buy Alkermes stock: You need to pick a stock brokerage, but don't worry - we've tested dozens of online stock brokerages and apps to help you determine where to buy Alkermes stock.
Deposit money your investment account: Pick your method of payment and add your information.
Research Alkermes stock: The Alkermes ticker symbol is ALKS. Is Alkermes stock a good investment? Should you buy shares of ALKS? How do ALKS's underlying business fundamentals look? Do top analysts think Alkermes is a good buy? Why has ALKS's stock price moved recently? (Hint: Our stock research tools can help you decide if ALKS is a good stock to buy).
Place your ALKS purchase: Decide if you will purchase ALKS shares at the current market price or use a limit order to buy ALKS stock at a particular price.
Get notifications regarding your ALKS investment: Create a watchlist to get the latest news on your new investment in Alkermes shares.
Step 1: Figure out where to buy Alkermes stock
You need a brokerage account to access the NASDAQ market and buy ALKS shares.
A brokerage account allows you to buy and sell a number of financial instruments, such as stocks, bonds, mutual funds, and ETFs.
Our recommended brokerage: eToro
In our opinion, eToro is the best brokerage. Here's why:
You can invest in stocks with 0% commissions: Invest without commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
Access to global financial markets: From Technology to Financial Services, New York to Shanghai — you can fill your portfolio with stocks from the globe's leading exchanges.
Social investing: eToro offers a community with more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by opening an account with eToro now.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Open a brokerage account
Now that you've chosen your brokerage, you'll need to fill out some personal info so you are able to invest in ALKS stock today.
Once you have figured out the best place to buy Alkermes stock, it's absolutely critical to research their stock prior to buying, so you truly wrap your head around the risk as well as the opportunity.
Alkermes stock quick numbers
Fore. Rev. Growth
Fore. Earn. Growth
Jul 27, 2023
WallStreetZen was designed to help part-time investors do more accurate fundamental analysis in less time.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.